Suchergebnisse - "D'Arena, Giovanni"

PubPharm (10)

1

Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment : a retrospective multi-centre Italian experience

enthalten in: British journal of haematology | 2019

von Innocenti, I. | Morelli, F. | Autore, F. | +22

2

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2019

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

3

Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters : results from a retrospective, multicenter study of 374 patients

enthalten in: Leukemia & lymphoma | 2017

von D'Arena, G. | Simeon, V. | Laurenti, L. | +15

4

Complementary and alternative medicine use in patients with chronic lymphocytic leukemia : an Italian multicentric survey

enthalten in: Leukemia & lymphoma | 2014

von D'Arena, G. | Laurenti, L. | Coscia, M. | +18

5

The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms : a retrospective multicentric GIMEMA experience

enthalten in: American journal of hematology | 2011

von Laurenti, L. | Tarnani, M. | Nichele, I. | +17

6

Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

enthalten in: British journal of haematology | 2011

von Crowther-Swanepoel, D. | Di Bernardo, M. | Jamroziak, K. | +14

7

Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia

enthalten in: Hematological oncology | 2011

von Bulian, P. | Tarnani, M. | Rossi, D. | +14

8

Pamidronate versus observation in asymptomatic myeloma : final results with long-term follow-up of a randomized study

enthalten in: Leukemia & lymphoma | 2011

von D'Arena, G. | Gobbi, P. | Broglia, C. | +16

CommentIn: Leuk Lymphoma. 2011 May;52(5):736-7. - PMID 21401404

9

Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia : influence of biological parameters on the clinical outcome

enthalten in: Annals of hematology | 2011

von Laurenti, L. | De Padua, L. | Tarnani, M. | +11

10

A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

enthalten in: Cancer | 2008

von Musto, P. | Petrucci, M. | Bringhen, S. | +10

ErratumIn: Cancer. 2008 Nov 15;113(10):2835

1
[1]